baber/WOPTO huggingface dataset:
Patent IE-910590-A1 (IE)
Title: Polymers
IPC: C09D133/08
Filed: 1991-02-20
Abstract: The invention provides a co-polymer comprising a hub portion from which radiate from 3 to 8 arms, where the hub portion being the residue of a trifunctional to octafunctional thiol and each arm is an addition polymer comprising structural units and functional units where the functional units contain hydrolysable group-bearing silicon atoms, optionally additional functional units each of which contain crosslinking groups that are the same or different and that are compatible with each other and the hydrolysable group-containing silicon atoms and optionally auxiliary functional units containing wetting groups.
Patent LU-84103-A1 (LU)
Inventor: METZ PAUL
IPC: B22D41/62
Filed: 1982-04-22
Abstract: 1. Use of mould nozzles, especially nozzles for feeding a continuous casting mould, constituted by a duct provided with at least one electromagnetic inductor (11) creating a rotating movement in the metal (M), characterized in that the metal level in the mould is measured, in that one acts upon a system (120), that controls the metal flow into the mould (1) through said nozzle (12) in dependence of the metal level in the mould, in that the relative variation of said flow and said level is compared with data obtained experimentally and in that the power supplied to the electromagnetic inductor(s) is varied according to said comparision.
Patent MA-22181-A1 (MA)
Inventor: GREINER ALFRED
IPC: A01N37/18
Filed: 1991-06-11
Abstract: The present invention relates to a process for the control of fungal disease of plants by applying to the leaves of the plants: a) 2-(4-chlorobenzylidene)-5,5-diemthyl-1-(1H-1,2,4-triazol-1-ylmethyl)-1-cyclopentanol; b) one or more fungicides suitable for protecting against the said fungal diseases and to compositions which may be used in the process.
Patent MA-27483-A1 (MA)
Title: Derives d'azole-pyrimidines fondues
Inventor: SHIMADA MITSUYUKI
IPC: C07D471/14
Filed: 2005-04-29
Abstract: L'invention concerne de nouveaux dérivés d'azole-pyrimidines fondues, des procédés permettant de les préparer et des préparations pharmaceutiques les contenant. Les dérivés d'azole-pyrimidines fondues de la présente invention présentent une capacité renforcée d'inhibition de la phosphotidylinositol-3-kinase (P13K), notamment d'inhibition de la P13K-(gamma) et peuvent s'utiliser pour assurer la prophylaxie et le traitement de pathologies associées à la P13K et en particulier à l'activité de la P13K-(gamma). Les dérivés d'azole de la présente invention s'utilisent plus particulièrement dans le traitement et la prophylaxie des pathologies suivantes : troubles inflammatoires et immunorégulateurs. tels que l'asthme, la dermatite atopique, la rhinite, les maladies allergiques, la maladie pulmonaire obstructive chronique (COPD), le choc septique, les maladies des articulations, les pathologies auto-immunes telles que la polyarthrite rhumatoïde, et la maladie de Graves, le cancer, les troubles de contractilité du myocarde, l'insuffisance cardiaque, le thromboembolisme, l'ischémie et l'athérosclérose. Les composés de la présente invention s'utilisent également pour traiter l'hypertension pulmonaire, l'insuffisance rénale, l'hypertrophie cardiaque, de même que des troubles neurodégénératifs tels que la maladie de Parkinson, la maladie d'Alzheimer, le diabète et l'ischémie focale, ces pathologies se rapportant également à l'activité de la P13K, chez l'homme ou l'animal.
Patent MA-40121-A1 (MA)
Title: Béton élastique léger sous-couche de base avec du caoutchouc recyclé à partir de pneus mis au rebut avec réduction de bruit d'impact à la marche
Inventor: SGOBBA SARA
IPC: C04B111/60
Filed: 2015-10-02
Abstract: Un béton sous-couche de base prétraitée avec du caoutchouc recyclé à partir de pneus mis au rebut (pfu), est décrit.
Patent MA-41882-A1 (MA)
Title: Bioprocédé de production de produits chimiques renouvelables et de biocarburants par fermentation de baies de cactus du genre opuntia
Inventor: ETTAYEBI MOHAMED
IPC: C12P1/00
Filed: 2018-01-19
Abstract: Un bioprocédé évolutif et durable pour la production de biocarburants renouvelables à partir de baies de cactus plus communément appelées figues de barbarie, est décrit dans la présente invention. En outre, le procédé tel qu’il est décrit dans la présente invention est rentable, approprié sans conflit d’usage avec les substrats d'alimentation. En outre un tel bioprocédé constitue une stratégie de bio-raffinerie intéressante, permettant l'extraction de produits chimiques à valeur ajoutée et la production de carburants.
Patent MA-48054-A1 (MA)
Title: Utilisation des algues marines pour la lutte contre la pourriture molle de la pomme de terre en poste recolte
Inventor: ETAHIRI SAMIRA
IPC: A01N65/03
Filed: 2020-01-17
Abstract: Les maladies phytopathogènes sont un facteur limitant de la production agricole, d'où la nécessité de développer des techniques adéquates pour limiter les effets de ces maladies sur la productivité agricole. Les produits naturels sont de plus en plus demandés pour une agriculture durable, car l'utilisation aveugle de pesticides synthétiques conventionnels a eu un impact écologique et sanitaire néfaste (résistance aux ravageurs, contamination de l'environnement et des écosystèmes, perte de biodiversité, etc.). L'utilisation du produit végétal et des molécules naturelles devient indispensable pour permettre aux plantes de se protéger contre les ennemis naturels. La présente invention concerne l'utilisation d'algues pour lutter contre la pourriture molle de la patate pendant le stockage.
Patent UY-25806-A1 (UY)
Title: Formulaciones antiparasitarias que contienen avermectinas o milbemicinas.
Inventor: RICHARD WICKS STEPHEN
IPC: A61K31/365
Filed: 1999-11-17
Abstract: Una formulación antiparasitaria de acción prolongada que es adecuada para su aplicación por vía tópica y que contiene: a) un 0,1-50% p/v de una avermectina o milbemicina que presenta actividad contra endoparásitos o ectoparásitos; b) un 1-50% v/v de un éter monoalquílico (C1-4) de un dialquilen (C2-4) glicol; c) un antioxidante opcional; y opcionalmente d) un disolvente volátil q.s. v/v, tolerable por la piel.
Patent UY-26459-A1 (UY)
Title: 3,4-dihidroquinazolinas 5,6-disustituidas
Inventor: LANG PHILIP C
IPC: A61K31/517
Filed: 2000-11-29
Abstract: Se ha encontrado que los compuestos de fórmula (en donde X e Y, que pueden ser iguales o diferentes, que representan cada uno CI, Br o F) y tautómeros de los mismos, tienen mejores propiedades de reducción del recuento de plaquetas. También se proporcionan métodos para preparar sintéticamente los compuestos de fórmula (E) y sales de adición farmacéuticamente aceptables de los mismos y un método para reducir el recuento de plaquetas en un paciente mediante la administración al paciente de una cantidad efectiva reductora de plaquetas de un compuesto de fórmula (E) preferentemente junto con un portador farmacéuticamente aceptable. También se proporciona una composición farmacéutica que contiene un compuesto de fórmula (E) como ingrediente activo junto con excipientes farmacéuticamente acepables. Además se proporciona un compuesto de fórmula (E) para uso en terapia y el uso de un compuesto de fórmula (E) paraz preparar un medicamento para reducir el recuento de plaquetas en un paciente.
Patent UY-28265-A1 (UY)
Title: Derivados de 3-azabiciclo (3.2.1) octano
Inventor: COE JOTHAM WADSWORTH
IPC: A61P25/04
Filed: 2004-04-13
Abstract: La presente invención se refiere a derivados de 3-azabiciclo(3,2,1)octano, composiciones farmacéuticas que comprenden derivados de ese tipo y procedimientos para usar derivados de ese tipo para tratar estados de enfermedad, trastornos y afecciones mediados por receptores de opioides. La presente invención se refiere también en particular al uso de derivados de este tipo para tratar ciertos trastornos y afecciones, por ejemplo, síndrome e de intestino irritable, drogadicción, depresión, ansiedad, esquizofrenia y trastornos alimentarios, entre otros.
Patent UY-28557-A1 (UY)
Title: Antagonistas de receptores de acetilcolina muscarinicos
Inventor: BUSCH-PETERSEN JAKOB
Filed: 2004-10-12
Abstract: Se proporcionan antagonistas de receptores de acetilcolina muxcarínicos y métodos para usarlos.
Patent UY-30460-A1 (UY)
Title: Compuestos terapéuticos
Inventor: CHIEN RONGLIANG
IPC: A61P31/18
Filed: 2007-07-04
Abstract: La presente invencion proporciona compuestos de formula (I), o sales o solvatos de los mismos farmacéuticamente aceptables, procedimientos para prepararlos, procedimientos para usarlos y formulaciones farmacéuticas que los comprenden.
Patent UY-31042-A1 (UY)
Title: Combinación de antagonista del receptor de progesterona con un agonista y un antagonista de la hormona liberadora de hormona luteinizante para usar en enfermedades mediadas por brca
Inventor: KORR DANIEL
IPC: A61K31/57
Filed: 2008-04-22
Abstract: Combinación del antagonista del receptor de progesteorna 11B-(4-acetilfenil) -17B-hidroxi-17a(alfa)- ( 1,1,2,2,2-pentafluoroetil) -estra-4,9.dien-3-ona, o un derivado o un análogo de éste aceptable para uso farmacéutico, al menos un agonista o un antagonista de la hormona liberadora de hormona luteinizante, y uso de dicha combinación para la profilaxis y el tratamiento de enfermedades mediadas por BRCA1 o BRCA2. Los agonistas y los antagonistas de la hormona liberadora de hormona luteinizante que pueden combinarse con el compuesto 11B-(4-acetilfenil)-17b-hidroxi-17a (alfa)-(1,1,2,2,2 pentafluoroetil) -estra-4,9-dient-3-ona son, por ejemplo. gonadorelina, goserelina, triptorelina, buserelina, nafarelina, deslorelina, histrelina, antida, ramorelix, cetrorelix, antarelix, ORG30850, abarelix, ganirelix y leuprolina.
Patent UY-31419-A1 (UY)
Title: Nueva forma cristalina vi de la agomelatina, su procedimiento de preparacion y las composiciones farmacéuticas que la contienen
Inventor: LECOUVE JEAN-PIERRE
IPC: C07C233/00
Filed: 2008-10-23
Abstract: Forma cristalina VI del compuesto de formula (I): caracterizada por su diagrama de difraccion X sobre polvo. Medicamentos.
Patent DZ-958-A1 (DZ)
Inventor: FREUCHET ANTOINE
IPC: A21C15/00
Filed: 1986-07-14
Granted: 2004-09-13
Abstract: Apparatus comprising a grill having two hot plates (12 and 14) between which the products to be cooked are placed, and hot pins (26) carried by one (12) of the plates and on which pieces of bread are skewered so as to be heated and formed by means of a seat into the shape of the products. <IMAGE>
Patent ES-183775-A1 (ES)
Title: UNA INSTALACIoN PARA EL CALENTAMIENTO DE MATERIAS DIELÉCTRICAS.
Filed: 1948-05-20
Abstract: Instalación para el calentamiento de materias dieléctricas mediante el empleo de alta frecuencia, caracterizada por comprender una cavidad resonante en forma de cilindro plano con prolongaciones interiores que permiten concentrar el campo en una zona central reducida en la que se encuentra dispuesta la materia para tratar, estando conectada la cavidad por la línea de alta frecuencia a un generador resnatrón o magnetrón.
Patent ES-236109-A1 (ES)
Title: Method for the manufacture of methyl acrylate and methyl methacrylate monomers
IPC: C07C/
Filed: 1957-06-17
Abstract: Methyl acrylate monomer or methyl methacrylate monomer, free from polymers is obtained by treating directly in a single stage the aseotropic mixture of vapours coming from an esterification column, with that quantity of water or an aqueous solution of an alkali metal or alkaline earth metal salt which will condense the vapours and give an organic phase substantially free from dimethyl ether. In a typical example, the vapours of a methyl methacrylate esterification column were condensed with water containing 0.025% of hydroquinone. The temperature of the uncondensed vapours was 70-72 DEG C. and there were introduced into the distillation apparatus at the rate of 14.9 Kgs of methyl methacrylate, 9.6 Kgs of methanol, 3.8 Kgs of water and 1 Kg of dimethyl ether per hour. After cooling to 20-25 DEG C. 13.1 Kgs were collected per hour of an organic phase having 95.3% by weight of methyl methacrylate free from polymer, and 63 Kgs of an aqueous phase containing 14.6% methanol, 3.9% methyl methacrylate and 0.8% of dimethyl ether. The aqueous solution may contain 270 to 465 grams of calcium chloride per litre.
Patent ES-248693-A1 (ES)
Title: Process for the production of polymeric materials
IPC: C08F291/18
Filed: 1959-04-16
Abstract: Segmented polymers, i.e. graft and block copolymers and branched chain homopolymers, are produced by a process in which a normally solid thermoplastic high polymer is masticated in an oxygen-containing atmosphere at a temperature below 170 DEG C. whereby peroxy groups are formed in the polymer and is subsequently subjected to conditions causing the decomposition of peroxy groups in the presence of a monomeric compound containing one or more olefinic double bonds and capable of polymerization under the influence of free radicals, this step being carried out in the absence of a concentration of oxygen which would otherwise inhibit the polymerization. Preformed polymers specified are polythene, polypropylene, polyisobutylene, polystyrene, polyvinyl alcohol, polyvinyl acetate, polyvinyl and polyvinylidene chlorides, polytrifluorochloroethylene, polytetrafluoroethylene, polymethyl and polybutyl acrylates, polyacrylonitrile, polyvinyl pyridines, poly-N-vinyl pyrrolidone, polybutadiene, polyisoprene, polychloroprene, interpolymers of butadiene with styrene, acrylonitrile and methyl methacrylate, polyethylene glycols, polyesters, polyamides, polyurethanes, polyureas, polysulphonamides, polysiloxanes, natural rubber, cyclised rubber, rubber hydrochloride, chlorinated rubber, gutta percha, and cellulose esters, ethers and acetals. Monomeric compounds specified are acrylic and methacrylic acids and their methyl, ethyl and n-butyl esters, 2-ethoxyethyl and 2-chloroethyl methacrylates, ethylene dimethacrylate, acrylonitrile, methacrylonitrile, acrylamide, n-butyl acrylamide vinyl and vinylidene chlorides, methyl vinyl and methyl isopropenyl ketones, styrene, vinyl toluenes, vinyl toluene sulphonic acids, divinyl benzene, acenaphthalene, vinyl acetate, vinyl pyridines, vinyl carbazole, N-vinyl pyrrolidone, butadiene, isoprene and chloroprene. Polymerization may be induced by the action of heat, ultra-violet light or reducing agents which are preferably used in an aqueous phase in which the monomeric compound is dispersed or dissolved, suitable agents of this type being sulphites, bisulphites, phenyl sulphinic acid, phenylhydrazine, thio-beta-naphthol which may be used in conjunction with iron salts and sodium pyrophosphate, fructose in the presence of ferrous ions and polyamines. The examples describe the polymerization of methyl methacrylate in the presence of peroxidised polythene and polypropylene, and styrene in the presence of peroxidised polythene. In an Example (7) it is stated that the products formed by polymerizing styrene with peroxidised polythene may be given ion-exchange properties by sulphonation with sulphuryl chloride. Specification 857,798 is referred to.
Patent ES-257189-A1 (ES)
Title: Roller for transmission chain and the method of producing said roller
IPC: C21D9/40
Filed: 1960-03-30
Abstract: A method of producing a chain roller comprises forming the roller of mild steel, producing by any known method a diffusion alloy of at least one other element on the surface of the roller, heating and quenching the roller to produce a martensitic core and an austenitic surface layer and hardening the surface layer by work or ageing. The additional element is preferably chromium but may be Mn, Si, B, W, Mo, Ta, V, Ni, Co, Zr, Ti, U or Be. Immediately below the surface layer is a martensitic layer containing some of the additional element.
Patent ES-263053-A1 (ES)
Title: Method of preparing dialkylphenol-ethylene oxide adducts with relatively narrow molecular weight distribution
IPC: A01N25/30
Filed: 1960-12-06
Abstract: Ethylene oxide/dialkylphenol adducts containing an average of 2-25 -C2H4O- groups per mole are produced by reacting 2-25 moles ethylene oxide with a dialkylphenol of formula <FORM:0977072/C1/1> wherein X is alkyl of at least 3 carbon atoms and Y is alkyl, X+Y totalling 4-37 carbon atoms, in presence of an alkali metal or an alkali metal hydroxide, carbonate or alcoholate as catalyst, used in an amount of 10-80 moles/100 moles of dialkylphenol. In examples, dinonyl and dinonylphenols were reacted with various molar proportions of ethylene oxide within the stated range. U.S.A. Specifications 2,213,477 and 2,593,112 are referred to.ALSO:Ethylene oxide/dialkylphenol adducts containing an average of 2-25 -C2H4O- groups per mole are produced by reacting 2-25 moles ethy lene oxide with a dialkylphenol of formula <PICT:0977072/C3/1> wherein X is alkyl of at least 3 carbon atoms and Y is alkyl, X + Y totalling 4-37 carbon atoms, in presence of an alkali metal or an alkali metal hydroxide, carbonate or alcoholate as catalyst, used in an amount of 10-80 moles/100 moles of dialkylphenol. In examples, dinonyl and diarylphenols were reacted with various molar proportions of ethylene oxide within the stated range, e.g. 18, 20 or 22 moles (Example 1), or 25 moles (Example 3). The compounds are used as oil-soluble emulsifiers, examples of oils being kerosene and chlorinated camphene. U.S.A. Specifications 2,213,477 and 2,593,112 are referred to.ALSO:In Example 7, rust-inhibiting composition was prepared from a multigrade SAE10W-30 oil containing a metal sulphonate detergent and an oxyethylated dinonylphenol prepared from 9 mols. ethylene oxide. In Example 2, a composition was prepared from a 150 second neutral base oil containing a metal sulphonate and an oxyethylated dinonylphenol prepared from 6 mols. ethylene oxide.ALSO:Oil-soluble emulsifiers are consituted by ethylene oxide/dialkylphenol adducts containing an average of 2-25 -C2H4O- groups per mole (see Division C2). Emulsifiable concentrates in various solvents are exemplified: Example 3 relates to an emulsion of chlorinated camphene in kerosene in Example 5 an emulsion was prepared from 98 parts tap water and 2 parts of a 1% solution in a commercially available dormant spray oil of dinonyl phenol/8 moles ethylene oxide adduct. U.S.A. Specifications 2,213,477 and 2,593,112 are referred to.
Patent ES-265955-A1 (ES)
Title: Improvements in or relating to 9-substituted-1-azathiaxanthenes
IPC: C07D409/06
Filed: 1961-03-22
Abstract: The invention comprises compounds of the general formula <FORM:0975921/C1/1> and their acid addition salts, wherein R1 represents a hydrogen or halogen atom, each of R2 and R3 represent a hydrogen atom and each of R4 and R5 represents an alkyl group containing 4 or less carbon atoms or R5 together with R2 or R3 or R4 represents an alkylene group containing at most 4 carbon atoms in a straight chain with the proviso that when a heterocyclic radical is attached to carbon atom 9 of the azathiaxanthene nucleus, it must contain 5 or 6-members, and the preparation thereof by reacting an organic metal compound of the formula <FORM:0975921/C1/2> wherein Hal represents a chlorine, bromine or iodine atom, with a 1-azathiaxanthone of the formula <FORM:0975921/C1/3> hydrolyzing the reaction product to form a 1-azathiaxanthydiol of the formula <FORM:0975921/C1/4> and treating this with a dehydrating agent, and, if desired, reacting the base with an organic or inorganic acid to produce the acid addition salt. The process of the invention may be combined with one for the preparation of the halo-1-azathiaxanthones by heating a halogenothiophenol with a solution of a diazonium salt of 3-aminopyridine-2-carboxylic acid in the presence of an alkali metal hydroxide, converting the alkali-metal salt of 2-carboxypyridyl-3-halogenophenyl sulphide resulting thereby to the free acid and then cyclising the corresponding acid halide in the presence of a cyclization agent. Separation of the compounds of the invention into the individual stereoisomers and separation of the halo-1-azathiaxanthones into the individual positional isomers are carried out by fractional crystallization. m-Dichlorodiphenyldisulphide is formed as a byproduct in the reaction between the diazonium salt and m-chlorothiophenol above. Pharmaceutical compositions comprise the compounds of the invention and an inert carrier. The compounds show marked histamine inhibition, seratonin inhibition, narcosis potentiation, adrenolytic, sedative, antipyretic or hypothermal effects according to the nature of the substituent groups therein.
Patent ES-294821-A1 (ES)
Title: Thermoplastic bag
IPC: B65D30/18
Filed: 1963-12-24
Abstract: A block-bottom welded plastics bag is formed from a tubular blank 30 (Fig. 6) formed with at least two cut-outs 31 (311) and with slits 32 (321), 33 (331) deeper than the cut-outs. In the arrangement of Fig. 6 the end tabs 36, 37 are folded in and welded to one another, as at 38, 39 in Fig. 7, and then welded also at 40, 41 to the walls of the bag before the side flaps 34, 35 are folded over and welded together to form a hand hold. In an alternative arrangement (Fig. 1, not shown) four cut-outs (2), (21), (3), (31) are provided thus forming on the end tabs (A), (A1) flaps which can be folded outwardly as at (13), (Fig. 2, not shown) before the side flaps (12), (11) are overlapped to be welded together and to the flaps (13). In this construction the end tabs A, A1 are welded at (16) ... (19) to the side walls of the bag. Parts of the side walls are preferably folded in with the side flaps. The side flaps 34, 35 may be omitted from the construction of Figs. 6 and 7, or the welds 40, 41 may be omitted. The side flaps 34, 35 need not overlap, but may be welded instead to the end tabs. The omission of the welds 40, 41 may provide three openings, and these may be closed after the bag is filled by welding a strip of plastics film over the opening. Holes at the ends of the slits 4, 5 etc. may prevent tearing.
Patent ES-299722-A1 (ES)
Title: Improvements in radiological apparatus
IPC: G03B42/02
Filed: 1964-05-12
Abstract: In radiographic apparatus especially suitable for examination of, for example, the cranium, the X-ray arm 1 comprises a major portion 100 and a side portion 101, which enable the X-ray tube to be rotated along an arcuate path A, A1 about an axis (X, X1) (Fig. 1, not shown), or to move parallel to itself (Fig. 3, not shown). The portions 100, 101 form the sides OM, PQ of a parallelogram OMPQ, the other sides MP, QO being formed at the tube and at a disc 6. The parallelogram can be fixed as a rectangle by locking the tube in position at the end of the arm 1, using a lever 4. Then, only rotation of the arm about the axis (X, X1) is permitted, the object to be examined being located at a point on this axis. When the lever is released, the disc 6 is locked to a fixed support arm (3) by means of a finger engaging one of the holes 7 in the disc. This allows rotation of the portion 100 about (X, X1) and of the portion 101 which is pivoted to the disc but prevents the arm as a whole from rotating about (X, X1). Instead, a deformation of the parallelogram occurs and the tube is allowed to move parallel to itself. The arm 1 is mounted on a column (not shown), together with the fixed arm (3), the arms being slidable along the column to provide for vertical displacement of the X-ray tube. The tube 2 may be swivelled on an axis (Y, Y1) at the end of its arm and locked in any position by means of the lever 4. A scale 8 is provided for lining up the central ray from the tube with the point to be investigated.